Ganz, Melanie http://orcid.org/0000-0002-9120-8098
Kondermann, Daniel
Andrulis, Jonas
Knudsen, Gitte Moos
Maier-Hein, Lena
Funding for this research was provided by:
Carlsbergfondet (2013_01_0502)
Deutsche Forschungsgemeinschaft (SFB TRR 125)
Lundbeckfonden (R90-A7722)
National Institutes of Health (5R21EB018964-02)
Article History
Received: 14 January 2016
Accepted: 9 June 2016
First Online: 27 June 2016
Compliance with ethical standards
:
: Melanie Ganz, Daniel Kondermann, Jonas Andrulis and Lena Maier-Hein declare that they have no conflict of interest. Gitte Moos Knudsen has been an invited lecturer at Pfizer A/S, worked as a consultant and received grants from H. Lundbeck A/S and is a stockholder of Novo Nordisk/Novozymes. Furthermore, she is on the board of directors of the BrainPrize and Elsass Foundation and the Advisory Board of the Kristian Jebsen Foundation and has authored for FADL and served as editor for Elsevier (IJNP).
: All procedures followed were in accordance with the ethical standards of the responsible committees on human experimentation (institutional and national) and with the Declaration of Helsinki 1975, as revised in 2008. Informed consent was obtained from all patients for being included in the study.